← Back to Search

Wearable Sensors for Blood Cancers

N/A

Recruiting

Led By Surbhi Sidana

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 28 days

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to monitor the effects of CAR-T cancer cell therapy and improve the management of side effects. The study will use wearable sensors to track patients' physiological changes, analyze their molecular profiles, and

Who is the study for?

This trial is for adults over 18 with Multiple Myeloma, Lymphoma, or Leukemia who are undergoing CAR-T cell therapy at Stanford University. Participants must speak English and be able to use wearable devices and collect blood samples with the help of a caregiver.

What is being tested?

The study tests if a Biostrap arm band can accurately monitor changes in patients' bodies during CAR-T therapy to manage side effects better. It also involves analyzing biological data (multiomic profile) alongside sensor and clinical data.

What are the potential side effects?

While not testing drugs directly, this trial monitors for adverse events like Cytokine Release Syndrome and neurotoxicity that may occur from the underlying CAR-T cancer treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 28 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~28 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Microsampling

Safety of the microsampling device

Safety of wearable devices

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Device physiological monitoringExperimental Treatment1 Intervention

Patients will receive wearable sensor devices (Biostrap arm band)

Group II: MicrosamplingActive Control1 Intervention

Blood microsamples will be collected at start of conditioning chemotherapy, daily while in the hospital, and after leaving the hospital and outpatient appointments.

Group III: Biostrap mobile AppActive Control1 Intervention

Data collection from wearable sensor.

Do I qualify?Apply below to find out